HPV16-E7 Protein T Cell Epitope Prediction and Global Therapeutic Peptide Vaccine Design Based on Human Leukocyte Antigen Frequency: An In-Silico Study

Cervical cancer is the second most common leading cause of women's death due to cancer worldwide, about 528,000 patients’ cases and 266,000 deaths per year, related to human papillomavirus (HPV). Peptide-based vaccines being safe, stable, and easy to produce have demonstrated great potential to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahmani, Bahareh, Amini-bayat, Zahra, Ranjbar, Mohammad Mehdi, Bakhtiari, Nahid, Zarnani, Amir-Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320846/
https://www.ncbi.nlm.nih.gov/pubmed/32837456
http://dx.doi.org/10.1007/s10989-020-10089-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320846/
https://www.ncbi.nlm.nih.gov/pubmed/32837456
http://dx.doi.org/10.1007/s10989-020-10089-5

Ejemplares similares